gaintherapeutics.com - Multiplikator forward rega marang pendapatan GANX

Lambang korporat lan logo Gain Therapeutics, Inc. (GANX)

Gain Therapeutics, Inc. (GANX) develops drugs for the therapy of neurodegenerative pathologies, focusing on the Gaucher and Parkinson's disease markets. The forward P/S multiple provided by the GURU.Markets system demonstrates potential sales growth, while 653.80 reflects the most recent value of the metric. Gain Therapeutics, Inc. (GANX) diversifies risks by targeting proteins, and the implementation of AI platforms in R&D optimizes costs in the absence of commercial products.

GANX (gaintherapeutics.com) riwayat Rasio rega marang pendapatan sing dikarepake saka 04.07.2022 nganti 14.05.2024

GANX (Gain Therapeutics Inc.): rincian analitis lan laporan miturut indikator

Ringkesan analisis perusahaan:gaintherapeutics.com GANX
Sampel barang Gain Therapeutics

A conservative analysis of Gain Therapeutics, Inc. (GANX) requires benchmarking market value against expected cash flows to assess the premium paid for future growth. The market capitalization-to-projected revenue ratio, reflected via the forward P/S multiple, demonstrates the efficiency of a hybrid trial outsourcing model that maintains control over platforms, thereby minimizing operational risks and stabilizing the company's investment profile.

Pesaing Gain Therapeutics, Inc.

Multiplikator Forward P/S HCA (HCA Healthcare, Inc.)|Rasio rega marang pendapatan sing dikarepake THC (Tenet Healthcare)|FMS - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep solventum.com|EHC: Multiplikator Forward P/S|UHS - Rasio kapitalisasi marang dodolan sing dikarepake|DVA (DaVita Corp) - Multiplikator Forward P/S|RDNT: Rega forward marang dodolan|Multiplikator Forward P/S OPCH|SGRY (surgerypartners.com) - Rega forward marang dodolan|Multiplikator Forward P/S PINC (Premier Inc)|National Vision - Rasio rega marang prakiraan pendapatan|PGNY - Rasio rega marang prakiraan pendapatan|ARDT - Multiplikator Forward P/S|SEM: Multiplikator Forward P/S|astranahealth.com (ASTH) - Multiplikator Forward P/S|MD (mednax.com) - Multiplikator Forward P/S|Multiplikator Forward P/S usph.com|Multiplikator Forward P/S PNTG|Rasio kapitalisasi marang dodolan sing dikarepake Organogenesis Holdings|Multiplikator Forward P/S NUTX (nutexhealth.com)|Auna SA (AUNA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SBC: Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Jeuveau EOLS|CYH (Community Health Systems Inc) - Multiplikator forward rega marang pendapatan|SKIN: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan MDWD|BTMD: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan The Joint Corporation (JYNT)|Multiplikator Forward P/S DocGo Inc (DCGO)|Rega forward marang dodolan P3 Health Partners, Inc.|Multiplikator Forward P/S EUDA Health Holdings Limited EUDA|baselmedical.com - Multiplikator Forward P/S|CLGN: Rasio rega marang prakiraan pendapatan|Cuprina Holdings (Cayman) Ltd. (CUPR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Concord Medical|AMS (American Shared Hospital Services Inc) - Multiplikator Forward P/S|MEDIROM Corp (MRM) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ALBT|Rasio kapitalisasi marang dodolan sing dikarepake DIH Holding|Multiplikator Forward P/S XAGE (carmellcosmetics.com)|NIVF: Kapitalisasi marang prakiraan pendapatan|ATIP: Multiplikator forward rega marang pendapatan|CareMax Medical Group - Rasio rega marang pendapatan sing dikarepake|Kindly MD (KDLY) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan MODV|Rasio rega marang prakiraan pendapatan Novo Integrated Sciences Corp|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems SSY|Rasio rega marang prakiraan pendapatan IMAC Corp (BACK)